Pfizer Partners with Cipla for India Market

[{ "selector": ".cpzgo-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(calc(360px - 291px)) scale(0.15)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateX(0px) scale(1)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".elupc-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }]

5-Year Exclusive Agreement
Pfizer Limited has entered into a 5-year exclusive supply and marketing agreement with Cipla Limited for four of its brands in India

[{ "selector": ".fsqai-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".qklew-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Brands Covered Under the Deal
The agreement includes Corex Dx, Corex LS, Dolonex, and Neksium, which will now be marketed and distributed exclusively by Cipla

[{ "selector": ".muiat-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".rwrgn-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

Why Pfizer Chose Cipla
Cipla’s wide distribution network and strong market presence are expected to help these brands reach more patients across India

[{ "selector": ".sqrmx-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".jajjc-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Click Here

Business Impact
The partnership is expected to improve product reach while allowing Pfizer to focus on manufacturing and supply, with Cipla handling sales and distribution

[{ "selector": ".zgkxr-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-15px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".pkwbl-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(calc(600px - 550px))", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }]

With Our Subscription Plans

[{ "selector": ".sowpc-a", "duration": "500ms", "fill": "forwards", "delay": "0ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".ckdip-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "opacity": 0, "visibility" :"visible"}, {"offset": 1, "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".xcjjn-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateX(-299px)", "opacity": "1", "visibility" :"visible" }, {"offset": 1, "transform": "translateX(0)", "opacity": "1", "visibility" :"visible"} ] }, { "selector": ".wmjei-a", "duration": "500ms", "fill": "forwards", "delay": "500ms", "keyframes": [ {"offset": 0, "transform": "translateY(-33px)", "opacity": "1", "visibility" :"visible"}, {"offset": 1, "transform": "translateY(0)", "opacity": "1", "visibility" :"visible"} ] }] Open Demat A/C

Pfizer Partners with Cipla for India Market

5-Year Exclusive AgreementPfizer Limited has entered into a 5-year exclusive supply and marketing agreement with Cipla Limited for four of its brands in India

Brands Covered Under the DealThe agreement includes Corex Dx, Corex LS, Dolonex, and Neksium, which will now be marketed and distributed exclusively by Cipla

Why Pfizer Chose CiplaCipla’s wide distribution network and strong market presence are expected to help these brands reach more patients across India

Business ImpactThe partnership is expected to improve product reach while allowing Pfizer to focus on manufacturing and supply, with Cipla handling sales and distribution

With Our Subscription Plans

Open demat account in 5 minutes*

5-Year Exclusive Agreement
Pfizer Limited has entered into a 5-year exclusive supply and marketing agreement with Cipla Limited for four of its brands in India

Brands Covered Under the Deal
The agreement includes Corex Dx, Corex LS, Dolonex, and Neksium, which will now be marketed and distributed exclusively by Cipla

Why Pfizer Chose Cipla
Cipla’s wide distribution network and strong market presence are expected to help these brands reach more patients across India

Business Impact
The partnership is expected to improve product reach while allowing Pfizer to focus on manufacturing and supply, with Cipla handling sales and distribution